跳至主要内容
临床试验/NL-OMON22329
NL-OMON22329招募中不适用

Sentinel node biopsy in Low- and Intermediate endometrial cancer Management

Radboudumc0 个研究点目标入组 142 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
Radboudumc
入组人数
142

研究概览

简要总结

2020

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 18 years
  • Histological confirmed endometrioid adenocarcinoma of the endometrium grade 1 or 2 on microcurettage

排除标准

  • Patients with high-risk type 1 endometrial cancer stage (IB grade 3) or type 2 endometrial cancer (defined as > 10% of the specimen is serous or clear cell type) of any grade and stage.
  • Patients with intermediate- risk stage IA grade 3 type 1 endometrial cancer

研究者

发起方
Radboudumc

相似试验